Evidence map›Paper›PMID 37085309›Full record

ArticleBMJ open2023

Predominance of non-

Upendo Ozeniel Kibwana, Joel Manyahi, Doreen Kamori, Martha Mushi, Ambele M Mwandigha, Mtebe Majigo

Abstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Microorganisms · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Upendo Ozeniel KibwanaDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania pendokibwana@gmail.com.ORCID 0000-0002-5401-872X
Joel ManyahiDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Doreen KamoriDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.ORCID 0000-0001-5162-6554
Martha MushiDepartment of Microbiology and Immunology, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
Ambele M MwandighaDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Mtebe MajigoDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.ORCID 0000-0003-3726-2816

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to determine the oral carriage prevalence of

designA hospital-based cross-sectional study.

settingThe study was conducted at a tertiary-level cancer hospital Ocean Road Cancer Institute (ORCI), Dar es Salaam, Tanzania.

participantsWe enrolled 196 participants who consented to join the study. Oral swabs were collected from all participants and inoculated onto Sabouraud dextrose agar supplemented with 50 mg/mL gentamicin and 50 mg/mL chloramphenicol, and chromogenic agar for phenotypic identification of PRIMARY OUTCOME: The study reported the high prevalence of oral carriage of

resultsA total of 196 participants were enrolled in the study. The overall oral carriage of

conclusionThe oral carriage of

Indexed as

Antifungal AgentsNeoplasmsAdultAgarCandidaCross-Sectional StudiesFluconazoleHumansMicrobial Sensitivity TestsTanzaniaAgarAntifungal AgentsFluconazolediagnostic microbiologyhead & neck tumoursinfectious diseasesmicrobiologymycology

Identifiers

PMID37085309
PMCPMC10124273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.